623 related articles for article (PubMed ID: 15382196)
1. Detrusor overactivity in spina bifida: how long does it need to be treated?
Ab E; Dik P; Klijn AJ; van Gool JD; de Jong TP
Neurourol Urodyn; 2004; 23(7):685-8. PubMed ID: 15382196
[TBL] [Abstract][Full Text] [Related]
2. Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.
Stöhrer M; Mürtz G; Kramer G; Schnabel F; Arnold EP; Wyndaele JJ;
Eur Urol; 2007 Jan; 51(1):235-42. PubMed ID: 16698176
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters.
Humblet M; Verpoorten C; Christiaens MH; Hirche H; Jansen K; Buyse G; van Gool JD
Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114
[TBL] [Abstract][Full Text] [Related]
4. Effects of intravesical electrical stimulation therapy on urodynamic patterns for children with spina bifida: a 10-year experience.
Choi EK; Hong CH; Kim MJ; Im YJ; Jung HJ; Han SW
J Pediatr Urol; 2013 Dec; 9(6 Pt A):798-803. PubMed ID: 23177928
[TBL] [Abstract][Full Text] [Related]
5. An artificial somatic-autonomic reflex pathway procedure for bladder control in children with spina bifida.
Xiao CG; Du MX; Li B; Liu Z; Chen M; Chen ZH; Cheng P; Xue XN; Shapiro E; Lepor H
J Urol; 2005 Jun; 173(6):2112-6. PubMed ID: 15879861
[TBL] [Abstract][Full Text] [Related]
6. Propiverine vs oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational cohort study.
Madersbacher H; Mürtz G; Alloussi S; Domurath B; Henne T; Körner I; Niedeggen A; Nounla J; Pannek J; Schulte-Baukloh H; Schultz-Lampel D; Bock P; Strugala G
BJU Int; 2009 Mar; 103(6):776-81. PubMed ID: 19007380
[TBL] [Abstract][Full Text] [Related]
7. Urodynamic parameters development and complications of clean intermittent self-catheterization in Chinese schoolchildren with neurogenic underactive bladder.
Wang QW; Song DK; Zhang XP; Wu YD; Zhang RL; Wei JX; Wen JG
Urol Int; 2011; 86(4):461-5. PubMed ID: 21555862
[TBL] [Abstract][Full Text] [Related]
8. The effect of oxybutynin on structural changes of the obstructed guinea pig bladder.
Scheepe JR; de Jong BW; Wolffenbuttel KP; Arentshorst ME; Lodder P; Kok DJ
J Urol; 2007 Oct; 178(4 Pt 2):1807-12. PubMed ID: 17707007
[TBL] [Abstract][Full Text] [Related]
9. Treatment of neurogenic bladder dysfunction in infants and children with neurospinal dysraphism with clean intermittent (self)catheterisation and optimized intravesical oxybutynin hydrochloride therapy.
Buyse G; Verpoorten C; Vereecken R; Casaer P
Eur J Pediatr Surg; 1995 Dec; 5 Suppl 1():31-4. PubMed ID: 8770576
[TBL] [Abstract][Full Text] [Related]
10. Does the absence of anal reflexes guarantee a "safe bladder" in children with spina bifida?
Marshall DF; Boston VE
Eur J Pediatr Surg; 2001 Dec; 11 Suppl 1():S21-3. PubMed ID: 11813129
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction.
Franco I; Horowitz M; Grady R; Adams RC; de Jong TP; Lindert K; Albrecht D
J Urol; 2005 Jan; 173(1):221-5. PubMed ID: 15592080
[TBL] [Abstract][Full Text] [Related]
12. Effect of pelvic floor interferential electrostimulation on urodynamic parameters and incontinency of children with myelomeningocele and detrusor overactivity.
Kajbafzadeh AM; Sharifi-Rad L; Baradaran N; Nejat F
Urology; 2009 Aug; 74(2):324-9. PubMed ID: 19476983
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of oxybutynin transdermal system in spinal cord injury patients with neurogenic detrusor overactivity and incontinence: an open-label, dose-titration study.
Kennelly MJ; Lemack GE; Foote JE; Trop CS
Urology; 2009 Oct; 74(4):741-5. PubMed ID: 19628264
[TBL] [Abstract][Full Text] [Related]
14. [Video-urodynamic studies on 1800 patients with neurogenic bladder].
JU YH; LIAO LM; LI D; FU G; LIANG WL; XIONG ZS; WU J; SHI WB; HAN CS
Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(20):1525-8. PubMed ID: 19094643
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of transdermal and oral oxybutynin in children with neurogenic detrusor overactivity.
Cartwright PC; Coplen DE; Kogan BA; Volinn W; Finan E; Hoel G
J Urol; 2009 Oct; 182(4):1548-54. PubMed ID: 19683731
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, tolerability and safety of propiverine hydrochloride in children and adolescents with congenital or traumatic neurogenic detrusor overactivity--a retrospective study.
Grigoleit U; Mürtz G; Laschke S; Schuldt M; Goepel M; Kramer G; Stöhrer M
Eur Urol; 2006 Jun; 49(6):1114-20; discussion 1120-1. PubMed ID: 16542772
[TBL] [Abstract][Full Text] [Related]
17. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
[TBL] [Abstract][Full Text] [Related]
18. The influence of bowel management on urodynamic findings in spina bifida children with detrusor overactivity and detrusor sphincter dyssynergia.
Milivojevic S; Milic N; Lazovic JM; Radojicic Z
J Pediatr Urol; 2020 Oct; 16(5):556.e1-556.e7. PubMed ID: 32376289
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting renal scar development in children with spina bifida.
Ozel SK; Dokumcu Z; Akyildiz C; Avanoglu A; Ulman I
Urol Int; 2007; 79(2):133-6. PubMed ID: 17851282
[TBL] [Abstract][Full Text] [Related]
20. [Physiology and evaluation of overactive bladder].
Amarenco G; Leroi AM
Neurochirurgie; 2003 May; 49(2-3 Pt 2):358-66. PubMed ID: 12746711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
